Neurological Biomarkers Market is estimated to reach US$ 24.83 Billion by 2032, growing at a CAGR of 13.00% from 2024 to 2032 | PMR

According to an exhaustive report by Polaris Market Research, the global neurological biomarkers market is poised for significant growth over the next decade. In 2023, global sales income reached USD 8.29 billion. Predicted to boost at a robust Compound Annual Growth Rate (CAGR) of 13.00%, the market is estimated to reach USD 24.83 billion by 2032.

Ordinary neurological illnesses involve stroke, motor neuron disease, Alzheimer's disease, Parkinson's disease, and Huntington's disease. Several neurodegenerative diseases allocate homogenous indicators and attributes, and the chore of diagnosis is frequently daunting. Thus, substantial research is accepted to traverse both clinical attributes and molecular procedures that cause these illnesses to recognize features to help diagnosis. Thus, biomarkers are crucial in diagnosing neurological disorders.

𝑮𝒆𝒕 𝑬𝒙𝒄𝒍𝒖𝒔𝒊𝒗𝒆 𝑺𝒂𝒎𝒑𝒍𝒆 𝑷𝒂𝒈𝒆𝒔 𝒐𝒇 𝑻𝒉𝒊𝒔 𝑹𝒆𝒑𝒐𝒓𝒕: https://www.polarismarketresearch.com/industry-analysis/neurological-biomarkers-market/request-for-sample

𝑮𝒓𝒐𝒘𝒕𝒉 𝑭𝒂𝒄𝒕𝒐𝒓𝒔 𝒂𝒏𝒅 𝑶𝒑𝒑𝒐𝒓𝒕𝒖𝒏𝒊𝒕𝒊𝒆𝒔

• The market for neurological biomarkers is expanding due to the growing pervasiveness of neurological illnesses and the growing prevalence of Alzheimer's disease amongst the geriatric population.

• Blood-based biomarkers play an important part in choosing accurate remedies and observing disease advancement. In the neurological biomarkers industry, this is epitomized by continuing research ventures and clinical studies carried out in hospitals to advance biomarker tests, which are anticipated to drive market growth.

• The ongoing research and advancements in the zone of neurology have charted the passage for inventive perception techniques and enhanced treatments for situations such as Schizophrenia, Parkinson's disease, Alzheimer's, and more.

𝑪𝒐𝒎𝒑𝒆𝒕𝒊𝒕𝒊𝒐𝒏 𝑫𝒆𝒆𝒑 𝑫𝒊𝒗𝒆:

The market is depicted by fierce contesting with traditional players depending on progressive technology, high standard commodities, and robust brand depiction to push revenue growth. These firms engage in several procedures, such as R&D, mergers and acquisitions, and technological inventions, to augment their product portfolios and sustain a competitive edge in the market.

𝑺𝒐𝒎𝒆 𝒐𝒇 𝒕𝒉𝒆 𝒑𝒓𝒐𝒎𝒊𝒏𝒆𝒏𝒕 𝒑𝒍𝒂𝒚𝒆𝒓𝒔 𝒐𝒑𝒆𝒓𝒂𝒕𝒊𝒏𝒈 𝒊𝒏 𝒕𝒉𝒆 𝒏𝒆𝒖𝒓𝒐𝒍𝒐𝒈𝒊𝒄𝒂𝒍 𝒃𝒊𝒐𝒎𝒂𝒓𝒌𝒆𝒓𝒔 𝒎𝒂𝒓𝒌𝒆𝒕 𝒊𝒏𝒄𝒍𝒖𝒅𝒆:

• Abbott
• Alseres Pharmaceuticals, Inc.
• BANYAN BIOMARKERS, INC.
• Bio-Rad Laboratories, Inc.
• DiaGenic ASA
• Johnson & Johnson Services, Inc.
• Merck & Co., Inc.
• Myriad Genetics, Inc.
• Quanterix
• Thermo Fisher Scientific, Inc.

𝑩𝒖𝒚 𝑵𝒐𝒘 𝑻𝒉𝒊𝒔 𝑷𝒓𝒆𝒎𝒊𝒖𝒎 𝑹𝒆𝒔𝒆𝒂𝒓𝒄𝒉 𝑹𝒆𝒑𝒐𝒓𝒕𝒔: https://www.polarismarketresearch.com/buy/2970/2

𝑵𝒆𝒖𝒓𝒐𝒍𝒐𝒈𝒊𝒄𝒂𝒍 𝑩𝒊𝒐𝒎𝒂𝒓𝒌𝒆𝒓𝒔 𝑴𝒂𝒓𝒌𝒆𝒕 𝑹𝒆𝒑𝒐𝒓𝒕 𝑯𝒊𝒈𝒉𝒍𝒊𝒈𝒉𝒕𝒔

• In 2022, the Proteomic segment dominated with the highest revenue share. Proteomic biomarkers play a pivotal role, especially when relying solely on mRNA expression falls short in revealing the functional implications of diverse post-translational modifications. In such scenarios, proteomic biomarkers become indispensable for accurately diagnosing the onset and progression of diseases by meticulously detecting protein signatures and post-translational changes.

These biomarkers have demonstrated remarkable effectiveness in unveiling the cellular alterations underlying complex and unexplained conditions like Alzheimer's disease (AD). Prominent proteomic biomarkers for AD include glial fibrillary acidic protein (GFAP), copper-zinc superoxide dismutase (SOD1), Aβ42, tau, and Aβ peptides. The continuous introduction of new products is expected to be a driving force behind market growth.

• Alzheimer's disease secured the largest market share in 2022 and is expected to continue its dominance during the forecast period. This trend is mainly driven by the rising prevalence of the disease and a heightened focus on early diagnosis and prompt treatment.

• In 2022, North America took the lead as the largest market. The neurological biomarkers market in North America holds a substantial share and is expected to exhibit a noteworthy CAGR in the upcoming forecast period. This growth is underpinned by several factors, including the high prevalence of neurological disorders and the surge in government initiatives aimed at supporting this sector.

Moreover, the market is set to gain from a growing influx of new product launches and an increasing demand for biomarkers. The region maintains robust funding for research and the development of innovative biomarkers, further contributing to market advancement.

𝑬𝒙𝒑𝒍𝒐𝒓𝒆 𝑻𝒉𝒆 𝑪𝒐𝒎𝒑𝒍𝒆𝒕𝒆 𝑪𝒐𝒎𝒑𝒓𝒆𝒉𝒆𝒏𝒔𝒊𝒗𝒆 𝑹𝒆𝒑𝒐𝒓𝒕 𝑯𝒆𝒓𝒆: https://www.polarismarketresearch.com/industry-analysis/neurological-biomarkers-market

𝑹𝒆𝒈𝒊𝒐𝒏𝒂𝒍 𝑺𝒄𝒐𝒑𝒆

The regions covered in the report are Europe, North America, Latin America, Asia Pacific, Middle East & Africa.

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝑺𝒆𝒈𝒎𝒆𝒏𝒕𝒂𝒍 𝑶𝒖𝒕𝒍𝒐𝒐𝒌

• By Type
o Metabolomic
o Genomic
o Imaging
o Proteomic
o Others

• By Application
o Autism Spectrum Disorder
o Parkinson's Disease
o Alzheimer's Disease
o Multiple Sclerosis
o Others

• By End Use
o Independent clinical diagnostic centers
o Research Organizations and Others
o Hospital & Hospital Laboratories

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐖𝐢𝐝𝐞-𝐫𝐚𝐧𝐠𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐟 𝐏𝐌𝐑'𝐬 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:

𝙐.𝙎. 𝙃𝙚𝙖𝙡𝙩𝙝𝙘𝙖𝙧𝙚 𝘿𝙞𝙨𝙘𝙤𝙪𝙣𝙩 𝙋𝙡𝙖𝙣 𝙈𝙖𝙧𝙠𝙚𝙩: https://www.polarismarketresearch.com/industry-analysis/us-healthcare-discount-plan-market
𝘾𝙤𝙨𝙢𝙚𝙩𝙤𝙫𝙞𝙜𝙞𝙡𝙖𝙣𝙘𝙚 𝙈𝙖𝙧𝙠𝙚𝙩: https://www.polarismarketresearch.com/industry-analysis/cosmetovigilance-market
𝘼𝙣𝙩𝙞-𝙊𝙗𝙚𝙨𝙞𝙩𝙮 𝙈𝙚𝙙𝙞𝙘𝙖𝙩𝙞𝙤𝙣 𝙈𝙖𝙧𝙠𝙚𝙩: https://www.polarismarketresearch.com/industry-analysis/anti-obesity-medication-market
𝙐.𝙎. 𝙃𝙚𝙖𝙡𝙩𝙝𝙘𝙖𝙧𝙚 𝙂𝙚𝙣𝙚𝙧𝙖𝙩𝙞𝙫𝙚 𝘼𝙄 𝙈𝙖𝙧𝙠𝙚𝙩: https://www.polarismarketresearch.com/industry-analysis/us-healthcare-generative-ai-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐈𝐧𝐟𝐨:
Polaris Market Research
30 Wall Street, 8th Floor,
New York City, NY 10005,
United States
Phone:+1-929 297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.